| Novo Nordisk Pharma AG - Insulatard HM, Injektionssuspension | | 45495 | | 02 | | Insulatard HM | | Injektionssuspension | | A10AC01 | | Insulin (human) | | 22.08.1986 | | |
| | Composition | | insulinum humanum ADNr isophanum 3.5 mg corresp. insulinum humanum ADNr isophanum 100 U.I., protamini sulfas, zinci chloridum, glycerolum, dinatrii phosphas dihydricus, natrii hydroxidum, acidum hydrochloridum, metacresolum, phenolum, aqua ad iniectabile q.s. ad suspensionem pro 1 ml corresp. natrium max. 0.78 mg. | | Packungsbestandteile | | Suspension injectable | | | | | | | | Principe actif | Concentr. |
|---|
| Insulinum Humanum adnr Isophanum | 3.5 mg/ml correspond Insulinum Humanum adnr Isophanum 100 UI/ml |
| | BAG: Principe actif | Concentr. |
|---|
| Insulinum Humanum adnr Isophanum | 100 UI |
| | | | Agents auxilliaires |
|---|
| Acidum Hydrochloridum | | Disodium Phosphate Dihydrate | | Glycerol | | Metacresol | | Sodium Hydroxide | | Phenol | | Protamini Sulfas | | Zinci Chlorure |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 10 ml | | | B | | Oui | | 035 | Flacon perforable à 10 ml | 11.41 | 28.85 | B | LS | Non |
|
|
